Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
30 Aug 2025 Job Information Organisation/Company FAPESP - São Paulo Research Foundation Research Field Engineering Researcher Profile Established Researcher (R3) Country Brazil Application Deadline
-
29 Aug 2025 Job Information Organisation/Company FAPESP - São Paulo Research Foundation Research Field Economics Researcher Profile Established Researcher (R3) Country Brazil Application Deadline 14
-
22 Aug 2025 Job Information Organisation/Company FAPESP - São Paulo Research Foundation Research Field Computer science Researcher Profile Established Researcher (R3) Country Brazil Application
-
23 Aug 2025 Job Information Organisation/Company FAPESP - São Paulo Research Foundation Research Field Biological sciences Researcher Profile Established Researcher (R3) Country Brazil Application
-
."The fellowship offers a monthly stipend of R$ 12,000.00 for an initial period of 12 months, with the possibility of renewal for an additional 4 months. A 10% technical reserve is also provided. The position
-
23 Aug 2025 Job Information Organisation/Company FAPESP - São Paulo Research Foundation Research Field Environmental science Researcher Profile Established Researcher (R3) Country Brazil Application
-
21 Aug 2025 Job Information Organisation/Company FAPESP - São Paulo Research Foundation Research Field Medical sciences Researcher Profile Established Researcher (R3) Country Brazil Application
-
CENTD, a multidisciplinary center studying molecular targets of inflammatory diseases, is offering a postdoctoral position for 12 months. The project aims to identify and validate new pharmacological
-
, Mexico, Colombia, Chile, and Peru. The position oversees a high-performing regional Country and Site Operations team, comprising Country Clinical Sciences Leads (CCSLs), Clinical Research Monitors (CRAs
-
CENTD, a multidisciplinary center studying molecular targets of inflammatory diseases, isoffering a postdoctoral position for 12 months. The project aims to identify and validate newpharmacological